Proxy Results, Corporate Action (Form 8-K)

Item 3.03. Material Modification to Rights of Security Holders.

Amendment of Certificate of Incorporation

As described in Item 5.03 below, which description is incorporated herein by reference, the stockholders of Globalink Investment Inc., a Delaware corporation ("Globalink") approved an amendment to the Amended and Restated Certificate of Incorporation of Globalink at the Special Meeting held on October 7, 2025, and Globalink has filed the Amendment of Charter with the Delaware Department of State, a copy of which is attached hereto as Exhibit 3.1.

Item 5.07 Submission of Matters to a Vote of Security Holders

On January 30, 2024, Globalink entered into that certain Merger Agreement (as amended and restated on May 20, 2024, further amended on March 6, 2025, April 18, 2025 and September 27, 2025, the "Business Combination Agreement"), with Alps Life Sciences Inc., an exempted company formed under the laws of the Cayman Islands ("Alps"), Alps Global Holding Pubco, an exempted company formed under the laws of the Cayman Islands ("PubCo"), Alps Biosciences Merger Sub, an exempted company formed under the laws of the Cayman Islands and a wholly-owned subsidiary of PubCo (the "Merger Sub"), GL Sponsor LLC, a Delaware limited liability company, in the capacity as Parent Representative thereunder and Dr. Tham Seng Kong, an individual, in the capacity as Seller Representative thereunder.

Pursuant to the Business Combination Agreement, the Business Combination between Globalink and Alps will be effected in two steps: (i) Globalink will merge with and into PubCo, with PubCo remaining as the surviving publicly traded entity (the "Redomestication Merger"); and (ii) Merger Sub will merge with and into Alps, resulting in Alps remaining as the surviving entity and being a wholly-owned subsidiary of PubCo (the "Acquisition Merger").

On October 7, 2025, Globalink held a special meeting of stockholders (the "Special Meeting") to consider and vote on the transactions contemplated by that Business Combination Agreement. At the Special Meeting, holders of 3,445,007 shares of Globalink common stock were present in person or by proxy, constituting a quorum for the transaction of business. Only stockholders of record as of September 16, 2025, the record date for the Special Meeting, were entitled to vote at the Special Meeting. As of the record date, 3,517,601 shares of Globalink common stock were outstanding and entitled to vote at the Special Meeting. The proposals listed below are described in more detail in Globalink's definitive proxy statement/prospectus, filed with the SEC on September 17, 2025 (the "Definitive Proxy Statement/Prospectus"). A summary of the final voting results at the Special Meeting is set forth below:

Proposal 1 - The Redomestication Merger Proposal

Globalink's stockholders approved Proposal 1 - the merger of Globalink with and into PubCo, with PubCo remaining as the surviving publicly traded entity. The votes cast were as follows: